A facility that helps researchers analyze immune system diseases.
Official title: Immunopathology Core
Funded at Oklahoma State University Stillwater · NIH-10881699 · Data updated 2026-11-12
This study is all about helping scientists at Oklahoma State University understand how the immune system works and why it sometimes doesn't, which could lead to better treatments for people with immune-related health issues.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma State University Stillwater NIH-funded |
| Lab location | 1 site (Stillwater, United States) |
| Project start | July 5, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $130,094 |
| NIH project number | 5P30GM149368-02 |
| Project ID | NIH-10881699 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with immune system disorders or diseases that involve immune dysfunction.
✕Less likely to help
Patients with conditions unrelated to immune dysfunction may not receive any benefit from this research.
What this research studies
The Immunopathology Core Laboratory at Oklahoma State University provides essential support for biomedical researchers by offering advanced technology and expertise in immunopathologic analyses. This facility enables researchers to conduct complex studies on immune dysfunction and disease mechanisms by providing access to cutting-edge assays, tissue processing, and expert data analysis. Patients may benefit indirectly as the research conducted here could lead to new insights and treatments for various immune-related conditions.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with immune dysfunction and related diseases.
How similar studies have gone: Other research initiatives utilizing similar core facilities have shown success in advancing our understanding of immunopathology and developing new therapeutic strategies.
Where this research is happening
-
Oklahoma State University Stillwater
Stillwater, United States Active
Researchers
- Principal investigator: Channappanavar, Rudragouda — Oklahoma State University Stillwater
- Study coordinator: Channappanavar, Rudragouda
Related research
Other NIH-funded projects on the same topics.
-
Iron and scar-forming cells in the lungs (IPF)
Researchers are exploring how iron in the lungs may drive the scarring seen in idiopathic pulmonary fibrosis and whether this could lead to new therapies.
-
Understanding how a calcium sensor helps Pseudomonas infections resist the immune system
This project looks at how the bacteria Pseudomonas aeruginosa uses a calcium sensor to survive and cause infections in people with conditions like cystic fibrosis.
-
ERK1/2 signaling and SARS-CoV-2 immune dysregulation in the lung
Aims to see if blocking ERK1/2 in immune cells can reduce dangerous lung inflammation from SARS-CoV-2 and boost antiviral defenses.
-
OADDL Testing Support for Vet-LIRN (Veterinary Network)
A veterinary diagnostic lab in Oklahoma will support national animal health surveillance and testing programs by handling clinical samples, animal feeds, environmental samples, and necropsies to help keep animal health and food safety safer.
-
How social life affects cognitive health in older adults in rural and urban areas
A study following older adults in rural and urban areas to see how social networks and daily activities relate to thinking skills over time.
-
Biophysical view of how enzymes work to help fight cancer
A scientist is studying how enzymes work on a deep, molecular level to help design better cancer drugs with fewer side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.